Jump to main content

yr 〜
yr

Search results 3

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab. 105 11

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab. 105 11
Digital博士論文障害者向け資料あり
Sakai, Kazuya, Someya, Tatsuhiko, Harada, Kaori, Yagi, Hideo, Matsui, Taei, Matsumoto, MasanoriFerrata Storti Foundation2019-12-19Haematologica
National Diet Library
  • Subject HeadingArterial Thrombosis Thrombotic Thrombocytopenic P...

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab.

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab.
Digital博士論文
Sakai, Kazuya, Someya, Tatsuhiko, Harada, Kaori, Yagi, Hideo, Matsui, Taei, Matsumoto, MasanoriFerrata Storti Foundation2019-12-19Haematologica105 11p.2631-2638
Available onlineOther Libraries in Japan
  • Subject HeadingArterial Thrombosis Thrombotic Thrombocytopenic P...

Management of extracranial cerebrovascular disease

Management of extracranial cerebrovascular disease
Paper図書
editors, Keith D. Calligaro, Dominic A. DeLaurentis, William H. Baker ; with 38 contributorsLippincott-Ravenc1997
Other Libraries in Japan

Reached to the end of result.

RSS